Cargando…

PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting

Detalles Bibliográficos
Autores principales:	Myerson, Jacob W, Allen, John S, Williams, Todd A, He, Li, Tollefsen, Douglas M, Lanza, Gregory, Caruthers, Shelton D, Wickline, Samuel A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304862/ http://dx.doi.org/10.1186/1532-429X-14-S1-O41

Ejemplares similares

Dual PARACEST and (19)F MR molecular imaging of fibrin clots with targeted perfluorocarbon nanoparticles
por: Cai, Kejia, et al.
Publicado: (2009)

Quantitative molecular imaging of angiogenesis-targeted fluorinated nanoparticles: new approaches for B(1)-mapping compensation for (19)F-MRI
por: Goette, Matthew J, et al.
Publicado: (2013)

Regional expression of myocardial sheet dysfunction in dystrophin-deficient cardiomyopathy elucidated with diffusion tensor MRI and optical calcium mapping
por: Cheng, Ya-Jian, et al.
Publicado: (2012)

Atherosclerosis endothelial activation quantification in vivo with fluorine magnetic resonance imaging and spectroscopy
por: Pan, Hua, et al.
Publicado: (2014)

Probing atherosclerotic angiogenesis with new manganese-based nanocolloid for T1-weighted MRI
por: Wang, Kezheng, et al.
Publicado: (2012)

Copper nanocolloids: a new thrombus molecular imaging approach to ruptured plaque
por: Pan, Dipanjan, et al.
Publicado: (2012)

EFFECT OF HEPARIN AND BIVALIRUDIN ON THE KINETICS OF CLOT FORMATION: VISCOELASTIC COAGULATION TESTING
por: Hasija, Suruchi, et al.
Publicado: (2017)

Quantitative cardiovascular magnetic resonance for molecular imaging
por: Winter, Patrick M, et al.
Publicado: (2010)

In Vivo quantitative imaging of angiogenesis-targeted PFOB nanoparticles in a hypercholesterol rabbit model using (19)F-MRI with ultra-short echo time balanced SSFP
por: Goette, Matthew J, et al.
Publicado: (2012)

Recent Advances in (19)Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions
por: Schmieder, Anne H., et al.
Publicado: (2016)

Cardiovascular MR function and coronaries: CMR 15 minute express
por: Watkins, Mary P, et al.
Publicado: (2013)

Thrombus-specific manganese-based “nanobialys” for MR molecular imaging of ruptured plaque
por: Pan, Dipanjan, et al.
Publicado: (2012)

Bicuspid Pulmonic Valve and Pulmonary Artery Aneurysm
por: Jamis-Dow, Carlos A., et al.
Publicado: (2014)

Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
por: Zhang, Huiying, et al.
Publicado: (2011)

Bivalirudin in percutaneous coronary intervention
por: Lehman, Sam J, et al.
Publicado: (2006)

Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics
por: Tran, Trung D, et al.
Publicado: (2007)

Is it time to switch to bivalirudin for ECMO anticoagulation?
por: Navaei, Amir, et al.
Publicado: (2023)

Anti-Angiogenesis Therapy in the Vx2 Rabbit Cancer Model with a Lipase-cleavable Sn 2 Taxane Phospholipid Prodrug using α(v)β(3)-Targeted Theranostic Nanoparticles
por: Pan, Dipanjan, et al.
Publicado: (2014)

Effect of fibrinogen concentrate on clot strength in trauma: preliminary results of an in vitro study
por: Meyer, MAS, et al.
Publicado: (2012)

Selection of an Aptamer Antidote to the Anticoagulant Drug Bivalirudin
por: Martin, Jennifer A., et al.
Publicado: (2013)

Bivalirudin and post-cardiotomy ECMO: a word of caution
por: Ranucci, Marco
Publicado: (2012)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
por: Boysan, Emre, et al.
Publicado: (2023)

Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity
por: Stephenne, Xavier, et al.
Publicado: (2012)

Primary bivalirudin anticoagulation for patients with an implantable ventricular assist device
por: Pieri, M, et al.
Publicado: (2014)

Safety, efficiency and cost effectiveness of Bivalirudin: A systematic review
por: Mehrzad, Melorin, et al.
Publicado: (2017)

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.
por: Galasso, G, et al.
Publicado: (2016)

A Review of Bivalirudin for Pediatric and Adult Mechanical Circulatory Support
por: Taylor, Tori, et al.
Publicado: (2020)

Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients
por: Giuliano, Katherine, et al.
Publicado: (2021)

Alterations in the elastic properties of the blood clots after the application of the continuous veno-venous hemofiltration in patients submitted to on-pump cardiac surgery
por: Pispirigkou, S, et al.
Publicado: (2013)

Clotting and COVID-19
por: Bull, Todd M.
Publicado: (2021)

Antithrombotic therapy in chronic liver disease: to clot or not to clot
por: Calvert, Peter, et al.
Publicado: (2021)

Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
por: Omo-Lamai, Serena, et al.
Publicado: (2023)

Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
por: Ramana, Ravi K, et al.
Publicado: (2008)

Distinct Effects of Unfractionated Heparin versus Bivalirudin on Circulating Angiogenic Peptides
por: Kapur, Navin K., et al.
Publicado: (2012)

Bivalirudin versus heparin in primary PCI: clinical outcomes and cost analysis
por: Deharo, Pierre, et al.
Publicado: (2018)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
por: Minhas, Abdul Mannan Khan, et al.
Publicado: (2017)

Bivalirudin/norepinephrine: Lack of efficacy and off label use: case report
Publicado: (2021)

Bivalirudin: Postoperative anaemia secondary to acute blood loss: case report
Publicado: (2021)

Simultaneous breast reconstruction
por: Bravo, F Gómez
Publicado: (2005)

To Clot or Not to Clot: Is That the Question?
por: Favaloro, Emmanuel J.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_skkn7i7qr99f6pa2saafcj0e4t